Novel Druggable Entities for the Treatment of Key Human Pain Indications

Grünenthal is a global leader in pain management, seeking new chemical entities and novel targets with first‑in‑class potential for the treatment of pain in humans. Grünenthal is also interested in discovering the global hotspots of pain research. They are also looking to unearth experts and leaders in the field within the scope of the call.

Approaches of Interest

• Analgesic candidate molecules demonstrating significant pain relief properties
• Targets must be linked to nociceptive pathways
• New compounds that provide pain relief/ therapeutic benefit in the...